Showing results (261-270 of 795) with videos related to
Sort By:
Pageof 80
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|September 19, 2001
Development process of an evidence-based guideline for the treatment of obesityA Gandjour, J Westenhöfer, A Wirth, et al.Diagnostic Microbiology and Infectious Disease|January 1, 1984
Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strainsP C Fuchs, A L Barry, R N Jones, et al.Veterinary Pathology|August 6, 2013
An exploratory evaluation of the utility of transcriptional and urinary kidney injury biomarkers for the prediction of aristolochic acid-induced renal injury in male ratsT C Fuchs, A Mally, A Wool, et al.Antimicrobial Agents and Chemotherapy|March 1, 1986
LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disksR N Jones, C Baker, A L Barry, et al.European Journal of Clinical Microbiology|February 1, 1985
Interpretive criteria for temocillin disk diffusion susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.Diagnostic Microbiology and Infectious Disease|May 1, 1985
Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limitsP C Fuchs, A L Barry, R N Jones, et al.Hypertension (Dallas, Tex. : 1979)|February 19, 2025
Clinical Trials in Hypertension: A Mathematical Endorsement for Diagnosis and TreatmentFlavio D Fuchs, Sandra C Fuchs, Otavio Berwanger, et al.Dermatopathology (Basel, Switzerland)|July 24, 2026
Diagnosis of Syphilis in Paraffin-Embedded Skin Biopsies: Comparison of Treponema pallidum Immunohistochemistry and Polymerase Chain Reaction in Primary and Secondary Stages of DiseaseCharlotte C Fuchs, Bastian Stoffers, Stephan A Braun, et al.Molecular & Cellular Oncology|June 16, 2017
The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancerDerek J Erstad, Andrew M Tager, Yujin Hoshida, et al.Journal of Clinical Microbiology|December 1, 1985
Cefotiam susceptibility testing criteriaP C Fuchs, A L Barry, R N Jones, et al.Pageof 80